Clinical Trial

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Name: A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) — clinical trial record (NCT06516965)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-15

Trial Details

NCT Number	NCT06516965
Lead Sponsor	Incyte Corporation
Conditions	Prurigo Nodularis
Enrollment	346 participants
Start Date	2024-10-10
Primary Completion	2026-10-19 (estimated)
Study Completion	2027-05-03 (estimated)
Updated on ClinicalTrials.gov	2026-04-14